Core/shell protein-reactive nanogels via a combination of RAFT polymerization and vinyl sulfone postmodification

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature 462(7272), 449–460 (2009).
  Medline CASGoogle Scholar
• 2 Moon JJ, Huang B, Irvine DJ. Engineering nano- and microparticles to tune immunity. Adv. Mater. 24(28), 3724–3746 (2012).
  Medline CASGoogle Scholar
• 3 De Koker S, Lambrecht BN, Willart MA et al. Designing polymeric particles for antigen delivery. Chem. Soc. Rev. 40(1), 320–339 (2011).
  Medline CASGoogle Scholar
• 4 Kasturi SP, Skountzou I, Albrecht RA et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470(7335), 543–547 (2011).
  Medline CASGoogle Scholar
• 5 Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
  Medline CASGoogle Scholar
• 6 Reddy ST, Van Der Vlies AJ, Simeoni E et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25(10), 1159–1164 (2007).
  Medline CASGoogle Scholar
• 7 Liu HP, Moynihan KD, Zheng YR et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507(7493), 519–522 (2014).
  Medline CASGoogle Scholar
• 8 Kwon YJ, James E, Shastri N, Frechet JMJ. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc. Natl Acad. Sci. USA 102(51), 18264–18268 (2005).
  Medline CASGoogle Scholar
• 9 Moon JJ, Suh H, Bershteyn A et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat. Mater. 10(3), 243–251 (2011).
  Medline CASGoogle Scholar
• 10 Scott EA, Stano A, Gillard M, Maio-Liu AC, Swartz MA, Hubbell JA. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials 33(26), 6211–6219 (2012).
  Medline CASGoogle Scholar
• 11 Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 33(4), 492–503 (2010).
  Medline CASGoogle Scholar
• 12 Narayan R, Nguyen H, Bentow JJ et al. Immunomodulation by imiquimod in patients with high-risk primary melanoma. J. Invest. Dermatol. 132(1), 163–169 (2012).
  Medline CASGoogle Scholar
• 13 Diebold SS, Kaisho T, Hemmi H, Akira S, Sousa CRE. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663), 1529–1531 (2004).
  Medline CASGoogle Scholar
• 14 Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3(2), 196–200 (2002).
  Medline CASGoogle Scholar
• 15 Nuhn L, Vanparijs N, De Beuckelaer A et al. pH-degradable imidazoquinoline-ligated nanogels for lymph node focused immune activation. Proc. Natl Acad. Sci. USA 113(29), 8098–8103 (2016). •• Illustrates the alluring properties of the employed nanogel platform in view of vaccine delivery, by means of lymph node-targeted immune activation when functionalized with a Toll-like receptor agonist.
  Medline CASGoogle Scholar
• 16 Dudek AZ, Yunis C, Harrison LI et al. First in human Phase I trial of 852A, a novel systemic Toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer. Clin. Cancer Res. 13(23), 7119–7125 (2007).
  Medline CASGoogle Scholar
• 17 Weigel BJ, Cooley S, Defor T et al. Prolonged subcutaneous administration of 852A, a novel systemic Toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies. Am. J. Hematol. 87(10), 953–956 (2012).
  Medline CASGoogle Scholar
• 18 Eberhardt M, Mruk R, Zentel R, Theato P. Synthesis of pentafluorophenyl(meth)acrylate polymers: new precursor polymers for the synthesis of multifunctional materials. Eur. Polym. J. 41(7), 1569–1575 (2005).
  CASGoogle Scholar
• 19 Li Y, Beija M, Laurent S et al. Macromolecular ligands for gadolinium MRI contrast agents. Macromolecules 45(10), 4196–4204 (2012).
  CASGoogle Scholar
• 20 Boyer C, Davis TP. One-pot synthesis and biofunctionalization of glycopolymers via RAFT polymerization and thiolene reactions. Chem. Commun. 40, 6029–6031 (2009).
  MedlineGoogle Scholar
• 21 De Koker S, Cui JW, Vanparijs N et al. Engineering polymer hydrogel nanoparticles for lymph node-targeted delivery. Eur. Polym. J. aAngew. Chem. Int. Ed. Engl. 55(4), 1334–1339 (2016).
  Medline CASGoogle Scholar
• 22 Nuhn L, Hirsch M, Krieg B et al. Cationic nanohydrogel particles as potential siRNA carriers for cellular delivery. ACS Nano 6(3), 2198–2214 (2012).
  Medline CASGoogle Scholar
• 23 Duong HTT, Marquis CP, Whittaker M, Davis TP, Boyer C. Acid degradable and biocornpatible polymeric nanoparticles for the potential codelivery of therapeutic agents. Macromolecules 44(20), 8008–8019 (2011).
  CASGoogle Scholar
• 24 De Coen R, Vanparijs N, Risseeuw MDP et al. pH-degradable mannosylated nanogels for dendritic cell targeting. Biomacromolecules 17(7), 2479–2488 (2016).
  Medline CASGoogle Scholar
• 25 Vanparijs N, Maji S, Louage B et al. Polymer-protein conjugation via a ‘grafting to’ approach – a comparative study of the performance of protein-reactive RAFT chain transfer agents. Polym. Chem. 6(31), 5602–5614 (2015).
  CASGoogle Scholar
• 26 Lyon RP, Setter JR, Bovee TD et al. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates. Nat. Biotechnol. 32(10), 1059–1062 (2014).
  Medline CASGoogle Scholar
• 27 Grover GN, Alconcel SNS, Matsumoto NM, Maynard HD. Trapping of thiol-terminated acrylate polymers with divinyl sulfone to generate well-defined semitelechelic Michael acceptor polymers. Macromolecules 42(20), 7657–7663 (2009). • Describes the postpolymerization modification of the thiocarbonyl end-group of RAFT polymers into a vinyl sulfone moiety.
  Medline CASGoogle Scholar
• 28 Convertine AJ, Benoit DSW, Duvall CL, Hoffman AS, Stayton PS. Development of a novel endosomolytic diblock copolymer for siRNA delivery. J. Control. Release 133(3), 221–229 (2009).
  Medline CASGoogle Scholar
• 29 Renz P, Kokkinopoulou M, Landfester K, Lieberwirth I. Imaging of polymeric nanoparticles: hard challenges for soft objects. Macromol. Chem. Phys. doi:10.1002/macp201600246 (2016).
  MedlineGoogle Scholar
• 30 Hartmann S, Nuhn L, Palitzsch B et al. CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccines. Adv. Healthc. Mater. 4(4), 522–527 (2015).
  Medline CASGoogle Scholar
• 31 Xu J, Boyer C, Bulmus V, Davis TP. Synthesis of dendritic carbohydrate end-functional polymers via RAFT: versatile multi-functional precursors for bioconjugations. J. Polym. Sci. Part A 47(17), 4302–4313 (2009).
  CASGoogle Scholar
• 32 Jia Z, Liu J, Boyer C, Davis TP, Bulmus V. Functional disulfide-stabilized polymer−protein particles. Biomacromolecules 10(12), 3253–3258 (2009).
  Medline CASGoogle Scholar
• 33 Heredia KL, Bontempo D, Ly T, Byers JT, Halstenberg S, Maynard HD. In situ preparation of protein – ‘smart’ polymer conjugates with retention of bioactivity. J. Am. Chem. Soc. 127(48), 16955–16960 (2005).
  Medline CASGoogle Scholar
• 34 Vanparijs N, De Coen R, Laplace D et al. Transiently responsive protein-polymer conjugates via a ‘grafting-from’ RAFT approach for intracellular co-delivery of proteins and immune-modulators. Chem. Commun. 51(73), 13972–13975 (2015).
  Medline CASGoogle Scholar